211 related articles for article (PubMed ID: 28184256)
21. Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer.
Grieshober L; Graw S; Barnett MJ; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
Cancer Causes Control; 2021 Nov; 32(11):1227-1236. PubMed ID: 34236573
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
23. CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas.
Paz MF; Yaya-Tur R; Rojas-Marcos I; Reynes G; Pollan M; Aguirre-Cruz L; García-Lopez JL; Piquer J; Safont MJ; Balaña C; Sanchez-Cespedes M; García-Villanueva M; Arribas L; Esteller M
Clin Cancer Res; 2004 Aug; 10(15):4933-8. PubMed ID: 15297393
[TBL] [Abstract][Full Text] [Related]
24. Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes.
Hu Z; Zhang H; Fan F; Wang Z; Xu J; Huang Y; Dai Z; Cao H; Zhang X; Liu Z; Cheng Q
Front Immunol; 2021; 12():737650. PubMed ID: 34804019
[TBL] [Abstract][Full Text] [Related]
25. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
[TBL] [Abstract][Full Text] [Related]
26. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
[TBL] [Abstract][Full Text] [Related]
27. Mutant IDH1 regulates the tumor-associated immune system in gliomas.
Amankulor NM; Kim Y; Arora S; Kargl J; Szulzewsky F; Hanke M; Margineantu DH; Rao A; Bolouri H; Delrow J; Hockenbery D; Houghton AM; Holland EC
Genes Dev; 2017 Apr; 31(8):774-786. PubMed ID: 28465358
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation and inflammation marker profiles associated with a history of depression.
Crawford B; Craig Z; Mansell G; White I; Smith A; Spaull S; Imm J; Hannon E; Wood A; Yaghootkar H; Ji Y; ; Mullins N; Lewis CM; Mill J; Murphy TM
Hum Mol Genet; 2018 Aug; 27(16):2840-2850. PubMed ID: 29790996
[TBL] [Abstract][Full Text] [Related]
29. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
30. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
31. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
32. Alu methylation serves as a biomarker for non-invasive diagnosis of glioma.
Chen J; Huan W; Zuo H; Zhao L; Huang C; Liu X; Hou S; Qi J; Shi W
Oncotarget; 2016 May; 7(18):26099-106. PubMed ID: 27028997
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetic and epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in human gliomas.
Qu M; Jiao H; Zhao J; Ren ZP; Smits A; Kere J; Nistér M
Neuropathol Appl Neurobiol; 2010 Apr; 36(3):198-210. PubMed ID: 20132488
[TBL] [Abstract][Full Text] [Related]
34. A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients.
Park SM; Choi EY; Bae M; Choi JK; Kim YJ
Clin Epigenetics; 2017; 9():73. PubMed ID: 28748001
[TBL] [Abstract][Full Text] [Related]
35. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
[TBL] [Abstract][Full Text] [Related]
36. Distinct methylation profiles of glioma subtypes.
Uhlmann K; Rohde K; Zeller C; Szymas J; Vogel S; Marczinek K; Thiel G; Nürnberg P; Laird PW
Int J Cancer; 2003 Aug; 106(1):52-9. PubMed ID: 12794756
[TBL] [Abstract][Full Text] [Related]
37. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
[TBL] [Abstract][Full Text] [Related]
38. Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer.
Choi Y; Kim JW; Nam KH; Han SH; Kim JW; Ahn SH; Park DJ; Lee KW; Lee HS; Kim HH
Gastric Cancer; 2017 Jul; 20(4):602-611. PubMed ID: 27665104
[TBL] [Abstract][Full Text] [Related]
39. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.
Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J
Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607
[TBL] [Abstract][Full Text] [Related]
40. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
